Publication: Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies
Loading...
Program
relationships.isAuthorOf
Author
Tokalı F. S.
Şenol H.
Yetke H. İ.
Hacıosmanoğlu E.
Advisor
Date
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Description
Source
Keywords
Keywords
Eczacılık , Meslek Bilimleri , Farmasötik Kimya , Sağlık Bilimleri , Pharmacology and Therapeutics , Professional Sciences , Pharmaceutical Chemistry , Health Sciences , Klinik Tıp (MED) , Yaşam Bilimleri (LIFE) , Farmakoloji ve Toksikoloji , FARMAKOLOJİ VE ECZACILIK , Clinical Medicine (MED) , Life Sciences (LIFE) , PHARMACOLOGY & TOXICOLOGY , PHARMACOLOGY & PHARMACY , Farmakoloji , Farmakoloji, Toksikoloji ve Eczacılık (çeşitli) , Genel Farmakoloji, Toksikoloji ve Eczacılık , Farmakoloji (tıbbi) , İlaç Rehberleri , Yaşam Bilimleri , Pharmacy , Pharmacology , Pharmacology, Toxicology and Pharmaceutics (miscellaneous) , General Pharmacology, Toxicology and Pharmaceutics , Pharmacology (medical) , Drug Guides , Life Sciences
Citation
Tokalı F. S., Şenol H., Yetke H. İ., Hacıosmanoğlu E., "Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies", ARCHIV DER PHARMAZIE, ss.1-16, 2023